Literature DB >> 9598734

Severe testotoxicosis phenotype associated with Asp578-->Tyr mutation of the lutrophin/choriogonadotrophin receptor gene.

J Müller1, B Gondos, S Kosugi, T Mori, A Shenker.   

Abstract

Testotoxicosis is a form of male precocious puberty caused by heterogeneous activating mutations in the gene for the lutrophin/choriogonadotrophin receptor (LHR). A patient with an unusually early and severe presentation of testotoxicosis, including profound Leydig cell hyperplasia, was found to have a sporadic mutation encoding Asp578-->Tyr. The severe testotoxicosis phenotype appears to be related to the strongly activating nature of the Tyr substitution.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9598734      PMCID: PMC1051288          DOI: 10.1136/jmg.35.4.340

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  17 in total

1.  A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty.

Authors:  A Shenker; L Laue; S Kosugi; J J Merendino; T Minegishi; G B Cutler
Journal:  Nature       Date:  1993-10-14       Impact factor: 49.962

2.  A model of the lutropin/choriogonadotropin receptor: insights into the structural and functional effects of constitutively activating mutations.

Authors:  Z Lin; A Shenker; R Pearlstein
Journal:  Protein Eng       Date:  1997-05

3.  Testotoxicosis. An unusual presentation and novel gene mutation.

Authors:  P A Clark; W L Clarke
Journal:  Clin Pediatr (Phila)       Date:  1995-05       Impact factor: 1.168

4.  Clinical expression correlates with location of rhodopsin mutation in dominant retinitis pigmentosa.

Authors:  M A Sandberg; C Weigel-DiFranco; T P Dryja; E L Berson
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-08       Impact factor: 4.799

5.  Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty.

Authors:  H Kremer; E Mariman; B J Otten; G W Moll; G B Stoelinga; J M Wit; M Jansen; S L Drop; B Faas; H H Ropers
Journal:  Hum Mol Genet       Date:  1993-11       Impact factor: 6.150

6.  Ocular findings in patients with autosomal dominant retinitis pigmentosa and rhodopsin, proline-347-leucine.

Authors:  E L Berson; B Rosner; M A Sandberg; C Weigel-DiFranco; T P Dryja
Journal:  Am J Ophthalmol       Date:  1991-05-15       Impact factor: 5.258

7.  Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness.

Authors:  V R Rao; G B Cohen; D D Oprian
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

8.  Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty.

Authors:  L Laue; W Y Chan; A J Hsueh; M Kudo; S Y Hsu; S M Wu; L Blomberg; G B Cutler
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

9.  Hazards of ketoconazole therapy in testotoxicosis.

Authors:  D Babovic-Vuksanovic; M D Donaldson; N A Gibson; A M Wallace
Journal:  Acta Paediatr       Date:  1994-09       Impact factor: 2.299

10.  Testicular leydig cell hyperplasia as a cause of familial sexual precocity.

Authors:  H K Schedewie; E O Reiter; I Z Beitins; S Seyed; V D Wooten; J F Jimenez; E J Aiman; G W DeVane; J F Redman; M J Elders
Journal:  J Clin Endocrinol Metab       Date:  1981-02       Impact factor: 5.958

View more
  8 in total

Review 1.  Potential Leydig cell mitogenic signals generated by the wild-type and constitutively active mutants of the lutropin/choriogonadotropin receptor (LHR).

Authors:  Mario Ascoli
Journal:  Mol Cell Endocrinol       Date:  2006-10-19       Impact factor: 4.102

Review 2.  Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor.

Authors:  Ana Claudia Latronico; Deborah L Segaloff
Journal:  Mol Cell Endocrinol       Date:  2006-10-18       Impact factor: 4.102

3.  Precocious Puberty in a Boy With Bilateral Leydig Cell Tumors due to a Somatic Gain-of-Function LHCGR Variant.

Authors:  Chelsi Flippo; Vipula Kolli; Melissa Andrew; Seth Berger; Tricia Bhatti; Alison M Boyce; Daniel Casella; Michael T Collins; Emmanuèle Délot; Joseph Devaney; Stephen M Hewitt; Thomas Kolon; Ashwini Mallappa; Perrin C White; Deborah P Merke; Andrew Dauber
Journal:  J Endocr Soc       Date:  2022-08-12

Review 4.  Hyperplasia in glands with hormone excess.

Authors:  Stephen J Marx
Journal:  Endocr Relat Cancer       Date:  2015-09-25       Impact factor: 5.678

5.  Absence of activating mutations in the hot spots of the LH receptor and Gs-alpha genes in Leydig cell tumors.

Authors:  T C A Vieira; J M Cerutti; M R Dias da Silva; R Delcelo; J Abucham
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

Review 6.  Glycoprotein G-protein Coupled Receptors in Disease: Luteinizing Hormone Receptors and Follicle Stimulating Hormone Receptors.

Authors:  Duaa Althumairy; Xiaoping Zhang; Nicholas Baez; George Barisas; Deborah A Roess; George R Bousfield; Debbie C Crans
Journal:  Diseases       Date:  2020-09-15

7.  The Luteinizing Hormone Receptor Knockout Mouse as a Tool to Probe the In Vivo Actions of Gonadotropic Hormones/Receptors in Females.

Authors:  Kim Carol Jonas; Adolfo Rivero Müller; Olayiwola Oduwole; Hellevi Peltoketo; Ilpo Huhtaniemi
Journal:  Endocrinology       Date:  2021-05-01       Impact factor: 4.736

8.  A Case of Familial Male-limited Precocious Puberty with a Novel Mutation

Authors:  Shilpa Gurnurkar; Emily DiLillo; Mauri Carakushansky
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-08-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.